Literature DB >> 645979

Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators.

R Hoover, C Bain, P Cole, B MacMahon.   

Abstract

A questionnaire was mailed to 97,364 married women, aged 26--50, resident in Greater Boston in 1970, requesting information on lifetime oral contraceptive (OC) use, reproductive history, education, and hospitalization experience in 1969; 65,843 women responded. In 1973 a second questionnaire was mailed to 37,292 of these women, including all OC users and an equal number of non-users matched on age, parity, education, and town of residence. This questionnaire related to use of OCs, other female hormones, and the menopause. OC use was most strongly related to age, with a sixfold increase in use from the oldest women (of whom 10 per cent had used OCs at some time) to the youngest. Use was directly related to education and mobility and inversely related to parity. Reasons for beginning and ceasing use differed for women of different ages and educational attainment. Thus, use of OCs varies with social and reproductive characteristics that are risk indicators for many diseases. OC use was associated with increased risk of hospitalization for thromboembolic disease (risk ratio = 1.5, 95 per cent confidence limits 1.2, 3.2) and for mental illness, hyperthyroidism, hypertension, and cancer of the cervix. OC users were hospitalized for many non-life threatening conditions 20 to 40 per cent more frequently than were non-users.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645979      PMCID: PMC1653930          DOI: 10.2105/ajph.68.4.335

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  36 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Increasing incidence of endometrial cancer in the United States.

Authors:  N S Weiss; D R Szekely; D F Austin
Journal:  N Engl J Med       Date:  1976-06-03       Impact factor: 91.245

3.  Oral contraceptives and hypertensive disease: a cybernetic overview.

Authors:  J H Laragh
Journal:  Circulation       Date:  1970-12       Impact factor: 29.690

4.  Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.

Authors: 
Journal:  Lancet       Date:  1973-06-23       Impact factor: 79.321

5.  Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study.

Authors:  J W Goldzieher; L E Moses; E Averkin; C Scheel; B Z Taber
Journal:  Am J Obstet Gynecol       Date:  1971-12-15       Impact factor: 8.661

6.  Thromboembolism and oral contraceptives: an epidemiologic case-control study.

Authors:  P E Sartwell; A T Masi; F G Arthes; G R Greene; H E Smith
Journal:  Am J Epidemiol       Date:  1969-11       Impact factor: 4.897

7.  The long-term effects of steroid contraceptives.

Authors:  R Doll
Journal:  J Biosoc Sci       Date:  1970-10

8.  Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids.

Authors:  M R Melamed; L G Koss; B J Flehinger; R P Kelisky; H Dubrow
Journal:  Br Med J       Date:  1969-07-26

9.  A study of factors affecting choice of contraceptives.

Authors:  H Dubrow; M R Melamed; B J Flehinger; R P Kelisky; L G Koss
Journal:  Obstet Gynecol Surv       Date:  1969-07       Impact factor: 2.347

10.  A STUDY OF THE AETIOLOGY OF CARCINOMA OF THE CERVIX UTERI.

Authors:  J T BOYD; R DOLL
Journal:  Br J Cancer       Date:  1964-09       Impact factor: 7.640

View more
  7 in total

1.  Oral contraceptives and non-contraceptive oestrogens in the risk of gallstone disease requiring surgery.

Authors:  C La Vecchia; E Negri; B D'Avanzo; F Parazzini; A Gentile; S Franceschi
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

2.  Oral contraceptives--another look.

Authors:  P E Sartwell
Journal:  Am J Public Health       Date:  1978-04       Impact factor: 9.308

3.  Characteristics of respondents and non-respondents to a mailed questionnaire.

Authors:  J Barton; C Bain; C H Hennekens; B Rosner; C Belanger; A Roth; F E Speizer
Journal:  Am J Public Health       Date:  1980-08       Impact factor: 9.308

Review 4.  Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women.

Authors:  M G Lê; P A Cabanes; V Desvignes; M F Chanteau; N Mlika; M F Avril
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

Review 5.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

6.  Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

7.  Menopausal oestrogens and breast cancer risk: an expanded case-control study.

Authors:  L A Brinton; R Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.